Background Congenital heart disease (CHD) can lead to failure to thrive. Decreased energy intake, malabsorption, increased energy requirements, and decreased growth factors (growth hormone/ insulin-like growth factor 1 axis) are related to malnutrition and growth retardation in children with CHD. Objective To compare the impact of cyanotic and acyanotic CHD on children's growth velocity (using the 2009 WHO growth velocity chart). Methods This study was conducted in patients less than 24 months of age with CHD in the Pediatric Cardiology Specialist Unit Dr. Moewardi Hospital, Surakarta, Central Java, from December 2016 to February 2017. Subjects' weights were evaluated at the beginning of the study and two months later. Data were compared to the WHO Growth Velocity chart and analyzed by Chi-square test. Results Of 46 patients with CHD (23 cyanotic, 23 acyanotic), 10 patients (21.7%) were identified with failure to thrive, i.e., < 5 th percentile. Significantly more children with acyanotic CHD were in the >5th percentile for growth velocity than were children with cyanotic CHD (OR 5.600; 95%CI 1.038 to 30.204; P=0.032 
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Reprint requests to: Dewi Awaliyah Ulfah. Sebelas Maret University Medical School, Jl. Ir. Sutami 36A Surakarta, Central Java, Indonesia. Phone +62271.664178, Fax. +62271637400, Email: fk@fk.uns.ac.id. C ongenital heart disease (CHD) is the most prevalent structural malformation, constituting 25% of all congenital anomalies, and is on the forefront of global medical issues. CHD occurs in 0.5-0.8% of all births. [1] [2] [3] Children with CHD often face impaired growth and development. Chen et al. reported delays in growth and development among children suffering from CHD compared to their normal counterparts. 4 The so-called failure to thrive (FTT) is not a disease unto itself, but rather a symptom of a general pathway caused by one or more medical, psychosocial, or environmental issues leading to stunted growth in a child. Evaluation of children with slowed or stunted growth is a challenge to pediatricians. 5 The etiology of failure to thrive among CHD patients is still obscure. Many factors may contribute to such a condition, including caloric intake, malabsorption, increased use of energy, relative hypoxia, and endocrine adaptation. 5, 6 We aimed to assess for a possible correlation between growth velocity and cyanotic and acyanotic CHD in children, using the 2009 WHO Growth Velocity Chart.
Methods
This prospective cohort study was done to compare the impact of cyanotic and acyanotic CHD on children's growth velocity. This study was carried out in the Pediatric Cardiology Specialist Unit at Dr. Moewardi Hospital, Surakarta, Central Java, from December 2016 to February 2017. The target population was cyanotic and acyanotic CHD patients <24 months of age. Parents or guardians of patients who fulfilled the research criteria provided informed consent and participated by filling in the research forms. Patients with Down syndrome, immune deficiency, dysmorphia, severe sepsis, thyroid anomalies, and gastrointestinal congenital malformation, were excluded. All patients aged <24 months with cyanotic or acyanotic CHD who fulfilled the inclusion criteria were included consecutively. Subjects' weights were evaluated at the beginning of the study and taken prospectively two months later. The data were recorded in the 2009 WHO Growth Velocity Chart and failure to thrive (FTT) was defined to be < 5 th percentile.
Data were processed and analyzed using SPSS 20.0 software. Basic characteristics of the subjects (age, sex, type of congenital heart disease, and weight) were presented in numbers and percentages. Correlations between the independent and dependent variables were analyzed by Chi-square test. Confounding variables were analyzed by logistical regression multivariate statistical analysis.
Results
This study was performed on 46 patients diagnosed with cyanotic or acyanotic congenital heart disease. Of 56 initial patients, 10 were excluded due to Down syndrome and/or congenital hypothyroidism. Table  1 shows that 58.7% of subjects were female and 41.3% were male. Most patients (65.2%) had no accompanying diseases (no acute upper respiratory tract infection, URI), whereas the remaining 34.8% had accompanying disease (acute URI). Most diagnoses of cyanotic CHD were tetralogy of Fallot (TOF) (30.4%), whereas most acyanotic CHD cases were diagnosed as atrial septal defect (ASD) (17.4%). In addition, 78.3% of patients did not have FTT, whereas the remaining 21.7% experienced FTT.
In subjects with cyanotic CHD, 34.8% had <5th percentile growth velocity, while in the acyanotic group, only 8.7% had similarly poor growth. Chisquare analysis revealed a significant correlation between the cyanotic CHD and impaired growth velocity. Also, patients with cyanotic CHD had 5.6 times higher risk of FTT (OR 5.600; 95%CI 1.038 to 30.204; P=0.032) compared to acyanotic CHD patients ( Table 2) .
As shown in Table 3 , 31.3% of URI patients had <5th percentile growth velocity compared to 16.7% of those without URI. Chi-square test revealed no significant association between URI and FTT (OR 2.273; 95%CI 0.545 to 9.479; P=0.253). 
Discussion
Children's growth velocity can be determined by the 2009 WHO Growth Velocity Chart. 7 The chart can also be used to assess children's vulnerability to FTT. A child is diagnosed with FTT if his/her weight is < 5 th percentile. We compared FTT in children with cyanotic to acyanotic CHD. Failure to thrive in CHD patients has no clear etiology, but may be due to multiple contributing mechanisms, including inadequate caloric intake, decreased appetite, malnutrition caused by hypoxia, malabsorption due to venous congestion, increased use of energy, relative hypoxia, increased need for oxygen, endocrine adaptation, and recurring respiratory infection. Hypoxia is a result of an imbalance between the demand and supply of oxygen. In addition, CHD causes chronic hypoxia, resulting in low levels of IGF-1 in the patient's endocrine system. [6] [7] [8] [9] [10] [11] This analytical study was done in patients who underwent routine medical check-ups at the Pediatrics Cardiology Specialist Unit at Dr. Moewardi Hospital, Surakarta. In our study, there were more female CHD patients (58.7%) than males (41.3%). In contrast, Mahapatra et al. reported that more male patients (54.5%) suffered from CHD compared to females, with a ratio of 1.2 to 1. However, Batte et al. found more females with CHD (57.2%) than males. 12, 13 The most common cause of acyanotic CHD is VSD (35-30%), and that of cyanotic CHD is TOF (5-7%). 12 In our study, the most of our cyanotic CHD subjects had TOF (61%), and most of our acyanotic subjects had ASD (35%). Nasiruzzaman et al. reported that the most prevalent cyanotic CHD etiology was TOF (26%). Similar to our findings, Atwa et al. reported that the frequency of ASD in acyanotic CHD was higher (28.8%) than VSD (28.2%). However, Mahapatra et al. in India reported VSD as the most prevalent acyanotic CHD (36.3%), and TOF as the most prevalent cyanotic CHD (11.25%). 12, 14, 15 In our study, 80% children with cyanotic CHD suffered from FTT. A previous study reported that 55.9% patients with CHD suffered from FTT. 16 Another study also reported FTT in 55% of neonates with VSD and TOF CHD.6 In addition, Harshangi et al. reported FTT complications among 56% of CHD patients. 17 Furthermore, Batrawy et al. reported that 60% cyanotic CHD patients suffered from growth anomalies. 9 Artiko et al. reported that patients with acyanotic CHD patent ductus arteriosus suffered from growth anomalies before a catheterization action was taken. 18 However, Nasiruzzaman et al. reported FTT occurrence in only 13% of children with CHD. 19 We found that cyanotic CHD patients have a 5.6 times higher risk of FTT (OR 5.600; 95%CI 1.038 to 30.204) compared to acyanotic CHD patients. Batte et al. in Uganda found that CHD patients who suffered from growth anomalies, as determined by the 2006 WHO Nutritional Chart, also showed similar findings of increased FTT. 13 In the ≥ 5 th percentile category, 69.4% of patients did not suffer from acute URI and did not experience FTT, whereas 50.0% of patients in the < 5 th percentile category suffered from URI 20 A limitation of our study was that other factors may cause failure to thrive, such as low body weight at birth, short pregnancy period, socioeconomic issues and malnutrition, none of which were evaluated in this study. In conclusion, cyanotic CHD poses higher risk of failure to thrive compared to acyanotic CHD.
